Literature DB >> 18522803

Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria.

Limin Shang1, Masayuki Fukata, Nanthakumar Thirunarayanan, Andrea P Martin, Paul Arnaboldi, David Maussang, Cecilia Berin, Jay C Unkeless, Lloyd Mayer, Maria T Abreu, Sergio A Lira.   

Abstract

BACKGROUND & AIMS: Several lines of evidence support a role for Toll-like receptor (TLR) signaling to protect the intestine from pathogenic infection. We hypothesized that TLR signaling at the level of the intestinal epithelium is critical for mucosal immune responses.
METHODS: We generated transgenic mice that express a constitutively active form of TLR4 in the intestinal epithelium (V-TLR4 mice). Lamina propria cellularity was evaluated by immunostaining and flow cytometry. Immunoglobulin (Ig) A levels in the stool and serum were measured by enzyme-linked immunosorbent assay. Chemokine and cytokine expression were analyzed by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay.
RESULTS: V-TLR4 transgenic mice reproduced normally and had a normal life span. Constitutive activity of TLR4 in the intestinal epithelium promoted recruitment of B cells and an increase in fecal IgA levels. Intestinal epithelial cells of V-TLR4 mice expressed higher levels of CCL20 and CCL28, chemokines known to be involved in B-cell recruitment, and of a proliferation-inducing ligand (APRIL), a cytokine that promotes T-cell-independent class switching of B cells to IgA. The changes in B-cell numbers and IgA levels were blocked by simultaneous expression in intestinal epithelial cells of M3, a herpes virus protein that binds and inhibits multiple chemokines.
CONCLUSIONS: TLR signaling in the intestinal epithelial cells significantly elevated the production of IgA in the intestine. This effect was mediated by TLR-induced expression of a specific set of chemokines and cytokines that promoted both recruitment of B cells into the lamina propria and IgA class switching of B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18522803      PMCID: PMC2598776          DOI: 10.1053/j.gastro.2008.04.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  61 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.

Authors:  Andrew J Macpherson; Therese Uhr
Journal:  Science       Date:  2004-03-12       Impact factor: 47.728

3.  Impaired IgA class switching in APRIL-deficient mice.

Authors:  Emanuela Castigli; Sumi Scott; Fatma Dedeoglu; Paul Bryce; Haifa Jabara; Atul K Bhan; Emiko Mizoguchi; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

4.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA.

Authors:  S Shimada; M Kawaguchi-Miyashita; A Kushiro; T Sato; M Nanno; T Sako; Y Matsuoka; K Sudo; Y Tagawa; Y Iwakura; M Ohwaki
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

6.  Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells.

Authors:  Puja Vora; Adrienne Youdim; Lisa S Thomas; Masayuki Fukata; Samuel Y Tesfay; Katie Lukasek; Kathrin S Michelsen; Akihiro Wada; Toshiya Hirayama; Moshe Arditi; Maria T Abreu
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

7.  In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse.

Authors:  Scott T Magness; Humberto Jijon; Nancy Van Houten Fisher; Ned E Sharpless; David A Brenner; Christian Jobin
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

8.  Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis.

Authors:  Lenka Frolova; Pavel Drastich; Pavel Rossmann; Klara Klimesova; Helena Tlaskalova-Hogenova
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

9.  CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

Authors:  E Castigli; F W Alt; L Davidson; A Bottaro; E Mizoguchi; A K Bhan; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes.

Authors:  R L Coffman; D A Lebman; B Shrader
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  78 in total

Review 1.  Regulation of mucosal IgA responses: lessons from primary immunodeficiencies.

Authors:  Andrea Cerutti; Montserrat Cols; Maurizio Gentile; Linda Cassis; Carolina M Barra; Bing He; Irene Puga; Kang Chen
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

Review 2.  Enterocytes: active cells in tolerance to food and microbial antigens in the gut.

Authors:  N Miron; V Cristea
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Expression and functional importance of innate immune receptors by intestinal epithelial cells.

Authors:  Rute Marques; Ivo G Boneca
Journal:  Cell Mol Life Sci       Date:  2011-10-08       Impact factor: 9.261

Review 4.  Epithelial crosstalk at the microbiota-mucosal interface.

Authors:  Jerry M Wells; Oriana Rossi; Marjolein Meijerink; Peter van Baarlen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-08       Impact factor: 11.205

5.  A "Toll" for Th17 cell expansion.

Authors:  Eduardo Davila; Jay Kolls
Journal:  J Leukoc Biol       Date:  2010-07       Impact factor: 4.962

6.  B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.

Authors:  Donna Kirkland; Alicia Benson; Julie Mirpuri; Reed Pifer; Baidong Hou; Anthony L DeFranco; Felix Yarovinsky
Journal:  Immunity       Date:  2012-02-01       Impact factor: 31.745

Review 7.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

8.  Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.

Authors:  Masayuki Fukata; Limin Shang; Rebeca Santaolalla; John Sotolongo; Cristhine Pastorini; Cecilia España; Ryan Ungaro; Noam Harpaz; Harry S Cooper; Greg Elson; Marie Kosco-Vilbois; Julia Zaias; Maria T Perez; Lloyd Mayer; Arunan S Vamadevan; Sergio A Lira; Maria T Abreu
Journal:  Inflamm Bowel Dis       Date:  2010-11-15       Impact factor: 5.325

9.  TLR4 and TLR21 expression, MIF, IFN-β, MD-2, CD14 activation, and sIgA production in chickens administered with EFAL41 strain challenged with Campylobacter jejuni.

Authors:  Karaffová V; Marcinková E; Bobíková K; Herich R; Revajová V; Stašová D; Kavuľová A; Levkutová M; Levkut M; Lauková A; Ševčíková Z; Levkut M
Journal:  Folia Microbiol (Praha)       Date:  2016-10-03       Impact factor: 2.099

10.  CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.

Authors:  Shinji Shimoda; Kenichi Harada; Hiroaki Niiro; Akinobu Taketomi; Yoshihiko Maehara; Koichi Tsuneyama; Kentaro Kikuchi; Yasuni Nakanuma; Ian R Mackay; M Eric Gershwin; Koichi Akashi
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.